{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:42:21Z","timestamp":1775151741512,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T00:00:00Z","timestamp":1376697600000},"content-version":"vor","delay-in-days":3425,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.virol.2003.11.013","type":"journal-article","created":{"date-parts":[[2004,4,9]],"date-time":"2004-04-09T05:21:57Z","timestamp":1081488117000},"page":"222-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Replication-dependent 65R\u2192K reversion in human immunodeficiency virus type 1 reverse transcriptase double mutant K65R + L74V"],"prefix":"10.1016","volume":"321","author":[{"given":"Prem L","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Nurpeisov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Skaggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Amat","family":"di San Filippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond F","family":"Schinazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2003.11.013_BIB1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/jvi.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"Adachi","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2003.11.013_BIB2","doi-asserted-by":"crossref","first-page":"19860","DOI":"10.1074\/jbc.271.33.19860","article-title":"The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptase","volume":"271","author":"Arion","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2003.11.013_BIB3","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/j.1460-2075.1996.tb00777.x","article-title":"Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme","volume":"15","author":"Back","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2003.11.013_BIB4","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1128\/AAC.44.7.1783-1788.2000","article-title":"In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (\u2212)-beta-d-dioxolane-guanosine and suppress resistance to 3\u2032-azido-3\u2032-deoxythymidine","volume":"44","author":"Bazmi","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2003.11.013_BIB5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy","volume":"267","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.virol.2003.11.013_BIB6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/384529a0","article-title":"Host factors and the pathogenesis of HIV-induced disease","volume":"384","author":"Fauci","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.virol.2003.11.013_BIB7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0166-3542(95)00985-X","article-title":"In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA)","volume":"32","author":"Foli","year":"1996","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2003.11.013_BIB8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.3313729","article-title":"Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line","volume":"238","author":"Folks","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.virol.2003.11.013_BIB9","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1128\/jvi.70.8.5662-5664.1996","article-title":"Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase","volume":"70","author":"Goudsmit","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2003.11.013_BIB10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/AAC.38.2.275","article-title":"Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2\u2032,3\u2032-dideoxycytidine and 2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine","volume":"38","author":"Gu","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2003.11.013_BIB11","doi-asserted-by":"crossref","first-page":"28118","DOI":"10.1016\/S0021-9258(18)46902-5","article-title":"The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2\u2032, 3\u2032-dideoxycytidine, 2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine, and 2\u2032,3\u2032-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro","volume":"269","author":"Gu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2003.11.013_BIB12","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1128\/AAC.39.8.1888","article-title":"K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenine","volume":"39","author":"Gu","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2003.11.013_BIB13","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1073\/pnas.92.7.2760","article-title":"Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2\u2032,3\u2032-dideoxycytidine 5\u2032-triphosphate and other drugs","volume":"92","author":"Gu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2003.11.013_BIB14","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1128\/AAC.43.10.2376","article-title":"Mechanism of action and in vitro activity of 1\u2032,3\u2032-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants","volume":"43","author":"Gu","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2003.11.013_BIB15","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/00002030-200010200-00008","article-title":"Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells","volume":"14","author":"Haddad","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2003.11.013_BIB16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1086\/315317","article-title":"Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group","volume":"181","author":"Harrigan","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2003.11.013_BIB17","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance","volume":"282","author":"Huang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.virol.2003.11.013_BIB18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1046\/j.1365-2141.2002.03680.x","article-title":"Improvement of interleukin 2 production, clonogenic capability and restoration of stromal cell function in human immunodeficiency virus-type-1 patients after highly active antiretroviral therapy","volume":"118","author":"Isgro","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.virol.2003.11.013_BIB19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.184.2.569","article-title":"Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes","volume":"184","author":"Loetscher","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2003.11.013_BIB20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00042560-200201010-00002","article-title":"Dioxolane guanosine, the active form of the prodrug diaminopurine dioxolane, is a potent inhibitor of drug-resistant HIV-1 isolates from patients for whom standard nucleoside therapy fails","volume":"29","author":"Mewshaw","year":"2002","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"10.1016\/j.virol.2003.11.013_BIB21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00002030-200001280-00012","article-title":"HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy","volume":"14","author":"Miller","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2003.11.013_BIB22","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1128\/JVI.77.2.1120-1130.2003","article-title":"Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine","volume":"77","author":"Murry","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2003.11.013_BIB23","series-title":"Introduction to Theoretical Population Genetics","author":"Nagylaki","year":"1992"},{"key":"10.1016\/j.virol.2003.11.013_BIB24","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1128\/JCM.41.7.3306-3311.2003","article-title":"Fluorescent dye terminator sequencing methods for quantitative determination of replication fitness of HIV-1 containing the codon 74 and 184 mutations in reverse transcriptase","volume":"41","author":"Nurpeisov","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2003.11.013_BIB25","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1128\/JVI.73.8.6293-6298.1999","article-title":"Second-site reversion of a human immunodeficiency type 1 reverse transcriptase mutant that restores enzyme function and replication capacity","volume":"73","author":"Olivares","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2003.11.013_BIB26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/317640","article-title":"Despite high concordance, distinct mutational and phenotypic drug resistance profiles in human immunodeficiency virus type 1 RNA are observed in gastrointestinal mucosal biopsy specimens and peripheral blood mononuclear cells compared with plasma","volume":"183","author":"Poles","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2003.11.013_BIB27","series-title":"In Human Cytokines: Their Role in Disease and Therapy","author":"Poli","year":"1995"},{"key":"10.1016\/j.virol.2003.11.013_BIB28","first-page":"65","article-title":"Mutations in retroviral genes associated with drug resistance","volume":"8","author":"Schinazi","year":"2000","journal-title":"Int. Antivir. News"},{"key":"10.1016\/j.virol.2003.11.013_BIB29","doi-asserted-by":"crossref","first-page":"48466","DOI":"10.1074\/jbc.M107003200","article-title":"Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue","volume":"276","author":"Selmi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2003.11.013_BIB30","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1128\/jvi.71.11.8846-8851.1997","article-title":"Attenuated replication of HIV-1 with a didanosine-selected reverse transcriptase mutation","volume":"71","author":"Sharma","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2003.11.013_BIB31","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.1128\/JVI.73.10.8448-8456.1999","article-title":"Decreased processivity of RT containing a didanosine-selected RT mutation: comparative evaluation of the effect of RT mutations in Leu74Val and Met184Val on viral fitness and RT processivity","volume":"73","author":"Sharma","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2003.11.013_BIB32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1996.0488","article-title":"AZT related mutation Lys70Arg in reverse transcriptase of human immunodeficiency virus confers decrease in susceptibility to ddATP in in vitro RT assay","volume":"223","author":"Sharma","year":"1996","journal-title":"Virol."},{"issue":"Pt. 1","key":"10.1016\/j.virol.2003.11.013_BIB33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/bj3480077","article-title":"Mutational analysis of Lys65 of HIV-1 reverse transcriptase","volume":"348","author":"Sluis-Cremer","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.virol.2003.11.013_BIB34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2002-06-1644","article-title":"Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys","volume":"101","author":"Sopper","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.virol.2003.11.013_BIB35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/135965359900400205","article-title":"In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA","volume":"4","author":"Wainberg","year":"1999","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.virol.2003.11.013_BIB36","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1097\/00002030-200010200-00007","article-title":"Molecular evidence for drug-induced compartmentalization of HIV-1 quasispecies in a patient with periodic changes to HAART","volume":"14","author":"Wang","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2003.11.013_BIB37","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.46.11.3437-3446.2002","article-title":"Molecular mechanism of resistance to human immunodeficiency virus type 1 on enzyme function and viral replication capacity","volume":"46","author":"White","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2003.11.013_BIB38","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1097\/00002030-200210180-00018","article-title":"The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients","volume":"16","author":"Winston","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2003.11.013_BIB39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.41.4.757","article-title":"Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy","volume":"41","author":"Winters","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2003.11.013_BIB40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1128\/AAC.38.2.282","article-title":"Resistance to 2\u2032,3\u2032-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase","volume":"38","author":"Zhang","year":"1994","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682203008432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682203008432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:27:54Z","timestamp":1758583674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682203008432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0042682203008432"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2003.11.013","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replication-dependent 65R\u2192K reversion in human immunodeficiency virus type 1 reverse transcriptase double mutant K65R + L74V","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2003.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}